🇺🇸 Movantik in United States

2,842 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Constipation — 361 reports (12.7%)
  2. Diarrhoea — 357 reports (12.56%)
  3. Drug Ineffective — 351 reports (12.35%)
  4. Pain — 350 reports (12.32%)
  5. Nausea — 307 reports (10.8%)
  6. Off Label Use — 247 reports (8.69%)
  7. Abdominal Pain — 238 reports (8.37%)
  8. Intentional Product Misuse — 222 reports (7.81%)
  9. Abdominal Pain Upper — 221 reports (7.78%)
  10. Vomiting — 188 reports (6.62%)

Source database →

Movantik in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Pain approved in United States

Frequently asked questions

Is Movantik approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Movantik in United States?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.